Utility of CC7 Transfer in Stroke Subtypes
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorDartmouth-Hitchcock Medical Center
About this trial
The purpose of this study is to evaluate the limb functional improvement after contralateral C7 root transfer in stroke patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation.
baseline Fugl-Meyer score below 33
Disqualifiers
pregnancy
Trial design
Design model
Single group
Treatments tested in this trial
Contralateral C7 root transfer for the treatment of spastic hemiparesis.
Procedure/SurgeryPerforming surgery to transfer the C7 nerve to treat stroke patients experiencing spastic hemiparesis.
Treatment groups
95 Participants
are divided into 1 treatment groupGroup A: Contralateral C7 root transfer for the treatment of spastic hemiparesis.Experimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change from baseline in arm function, as measured by the Fugl-Meyer upper-extremity scale.
The Fugl-Meyer is a widely used and highly recommended stroke-specific, performance-based measure of impairment with 5 domains and a possible 226 points.
Time frame
12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov